Home / Brands / Second Tokushima Factory, Otsuka Pharmaceutical
Second Tokushima Factory, Otsuka Pharmaceutical Recalls
4 recalls on record · May 1, 2024 to May 1, 2024 · Drugs
May 1, 2024DrugsFDA
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 5
Hazard: Cross Contamination with Other Products
May 1, 2024DrugsFDA
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 5
Hazard: Cross Contamination with Other Products
May 1, 2024DrugsFDA
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (
Hazard: Cross Contamination with Other Products
May 1, 2024DrugsFDA
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59
Hazard: Cross Contamination with Other Products